Leerink Partners Reiterates a Buy Rating on Disc Medicine (IRON) With an $85 Price Target

Jun 26, 2025 - 10:30
 0
Leerink Partners Reiterates a Buy Rating on Disc Medicine (IRON) With an $85 Price Target